NCT01290380View on ClinicalTrials.gov

A Study to Evaluate the Effects of ASA404 Alone or in Combination With Taxane-based Chemotherapies on the Pharmacokinetics of Drugs in Patients With Advanced Solid Tumor Malignancies

PHASE1TerminatedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

November 30, 2010

Conditions
Solid Tumor Malignancies
Interventions
DRUG

ASA404, DMXAA, DXAA

ASA404 (5,6-dimethylxantheone-4-acetic acid) DMXAA or DXAA

Trial Locations (2)

53792

University of Wisconsin & Paul P. Carbone Comprehensive Cancer Center, Madison

77030

The University of Texas Science Center at Houston, Houston

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY